Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT02259738
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- XuanwuH 2
- Registry
-
NCT02259738
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02259738. Allocation not applicable; single masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2014-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase
- Condition
- Cerebral Infarction
- Intervention (Drug)
- Human Urinary Kallidinogenase
- Intervention (Drug)
- Shuxuening injection
- Lead sponsor
- XuanwuH 2
Record details
- Record id
cardio:ct-nct02259738- Content hash
8b8e355b8d159ac9e8d9a8a3914827fc685947ff5804e0c0b8ed98000b56e673